# Adam Hodge on Retail Cannabis Sales and Patient Experience > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/retail-cannabis-sales-virginia-patient-access-strategy/ > **Published:** 2026-03-23T19:03:05-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T10:41:20-04:00 > **Clinical Summary:** Explore retail cannabis sales in Virginia with insights on strategy, customer experience, and patient access from Adam Hodge's interview. --- ✦ New CED Clinical Relevance  #70Notable Clinical Interest  Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News  |  CED Clinic Patient AccessRetail OperationsMissouriHealthcare DeliveryPatient Education Why This Matters Retail strategy and customer experience in cannabis dispensaries directly impacts patient access to appropriate products and quality of care. Independent retailers often serve as de facto healthcare touchpoints for cannabis patients, making their operational approaches clinically relevant for patient outcomes. Clinical Summary This appears to be an interview with Adam Hodge regarding retail operations in Missouri’s cannabis market. Without access to the specific content, the focus on customer experience and independent retail strategy suggests discussion of how dispensaries serve patients in Missouri’s medical and adult-use cannabis programs. Missouri represents a rapidly evolving cannabis market with both medical and recreational access. Clinical Perspective 🧠 Clinicians should be aware that dispensary practices vary significantly between operators and states. Patients benefit when retailers prioritize education over sales, maintain consistent product quality, and employ knowledgeable staff who can discuss effects and contraindications appropriately. 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/forum/cannabis-industry/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20Adam%20Hodge%20talks%20retail%20strategy%2C%20customer%20experience%2C%20and%20independent%20cannabis%20...%20%40drcaplan&url=https%3A//mogreenway.com/2026/03/23/adam-hodge-talks-retail-strategy-customer-experience-and-independent-cannabis-in-missouri/)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A//mogreenway.com/2026/03/23/adam-hodge-talks-retail-strategy-customer-experience-and-independent-cannabis-in-missouri/)[🦥 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20Adam%20Hodge%20talks%20retail%20strategy%2C%20customer%20experience%2C%20and%20independent%20cannabis%20...%20--%20via%20%40drcaplan.bsky.social%20https%3A//mogreenway.com/2026/03/23/adam-hodge-talks-retail-strategy-customer-experience-and-independent-cannabis-in-missouri/)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) 📰 Source: [https://mogreenway.com/2026/03/23/adam-hodge-talks-retail-strategy-customer-experience-and-independent-cannabis-in-missouri/](https://mogreenway.com/2026/03/23/adam-hodge-talks-retail-strategy-customer-experience-and-independent-cannabis-in-missouri/) Table of Contents - [FAQ](#FAQ)[What is the clinical relevance rating of this cannabis news?](#What_is_the_clinical_relevance_rating_of_this_cannabis_news) - [Which state does this cannabis news relate to?](#Which_state_does_this_cannabis_news_relate_to) - [What aspects of cannabis operations does this news cover?](#What_aspects_of_cannabis_operations_does_this_news_cover) - [How does this news relate to healthcare delivery?](#How_does_this_news_relate_to_healthcare_delivery) - [Why should healthcare professionals pay attention to this news?](#Why_should_healthcare_professionals_pay_attention_to_this_news) - [Related](#Related) ## FAQ #### What is the clinical relevance rating of this cannabis news? This news item has received CED Clinical Relevance rating #70, classified as “Notable Clinical Interest.” This indicates emerging findings or policy developments that healthcare professionals should monitor closely. #### Which state does this cannabis news relate to? This news specifically pertains to Missouri’s cannabis program. The content focuses on developments within Missouri’s [medical cannabis](https://cedclinic.com/therapeutic-benefits-of-thc/) regulatory framework. #### What aspects of cannabis operations does this news cover? The news addresses both patient access and retail operations within the [cannabis industry](https://cedclinic.com/cannabis-mold-contamination-risks-recall-safety/). These are key operational areas that impact how patients obtain [medical cannabis products](https://cedclinic.com/cannabis-infused-products-skin-diy-topical-recipes/). #### How does this news relate to healthcare delivery? This development affects healthcare delivery systems, particularly in how medical cannabis is integrated into [patient care](https://cedclinic.com/cannabis-cardiovascular-risk-impact/). It represents important policy or operational changes that could impact clinical practice. #### Why should healthcare professionals pay attention to this news? Healthcare professionals should monitor this because it represents emerging developments in cannabis policy or practice. Such changes can directly affect [patient care](https://cedclinic.com/cannabis-cardiovascular-risk-impact/) protocols and access to medical cannabis treatments. {“@context”: “https://schema.org”, “@type”: “NewsArticle”, “headline”: “Adam Hodge talks retail strategy, customer experience, and independent cannabis in Missouri”, “url”: “https://mogreenway.com/2026/03/23/adam-hodge-talks-retail-strategy-customer-experience-and-independent-cannabis-in-missouri/”, “datePublished”: “2026-03-23T19:01:40Z”, “about”: “adam hodge talks retail strategy customer”} [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [Retail cannabis sales in Virginia could begin next January – YouTube](https://cedclinic.com/virginia-cannabis-retail-sales-2026/) Learn about the upcoming launch of retail cannabis sales in Virginia and what it means for patients and retailers. [Watch Now](https://cedclinic.com/virginia-cannabis-retail-sales-2026/) [Week in Weed – April 25, 2026 – StratCann](https://cedclinic.com/weekly-cannabis-clinical-updates-april-25-2026/) Stay updated on the latest [cannabis industry](https://cedclinic.com/cannabis-mold-contamination-risks-recall-safety/) news including retail developments and regulatory changes. [Read More](https://cedclinic.com/weekly-cannabis-clinical-updates-april-25-2026/) [US (RI): Battle rages over adult-use cannabis stores](https://cedclinic.com/rhode-island-cannabis-licenses-adult-use-market-challenges/) Explore the challenges and debates surrounding adult-use cannabis retail stores in Rhode Island. [Explore Article](https://cedclinic.com/rhode-island-cannabis-licenses-adult-use-market-challenges/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).